FDA Inspection
CSL Plasma Inc.CSL Plasma Inc. – FDA Inspection, Jan 22, 2026
Record Details
This FDA Inspection record concerns CSL Plasma Inc., with an inspection on January 22, 2026, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 46603d65-6e7a-401d-bc91-38e9efb9ed5f
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1295526
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of CSL Plasma Inc.
14| Date | Classification | Office | Project area |
|---|---|---|---|
| July 31, 2026 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 26, 2026 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 5, 2026 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 25, 2026 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 8, 2026 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for CSL Plasma Inc.
- FDA Inspection 1329850 - 2026-07-31
- FDA Inspection 1325372 - 2026-06-26
- FDA Inspection 1307144 - 2026-03-05
- FDA Inspection 1305416 - 2026-02-25
- FDA Inspection 1298616 - 2026-01-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.